Atypical Antipsychotics and Parkinsonism [PDF]
Archives of Internal Medicine, 2005 Atypical antipsychotic agents are thought to be less likely than older typical agents to produce parkinsonism. This has not been well documented. We compared the risk of development of incident parkinsonism among older adults dispensed atypical relative to typical antipsychotics.Retrospective cohort study of all adults 66 years and older in Ontario. We
Rochon, Paula A. +12 more
openaire +4 more sources
Atypical Antipsychotics Induced Metabolic Syndrome [PDF]
Psikiyatride Güncel Yaklaşımlar, 2015 The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension.
Aysegul Demirel +2 more
doaj +2 more sources
Off-label use of atypical antipsychotics- Where are we? [PDF]
European Psychiatry, 2023 Introduction Nowadays, In the exercise of psychiatric clinical activity, the prescription of atypical antipsychotics is a widespread practice. However, despite the approval in the treatment of psychoses and bipolar affective disorder, where its ...
R. P. Vaz +9 more
doaj +2 more sources
Association of typical and atypical antipsychotics with mortality in older adults with schizophrenia: a 5-year multicenter prospective study [PDF]
Brazilian Journal of PsychiatryObjective: Due to the uncertainty whether atypical and typical antipsychotics have a stronger association with mortality among older people with schizophrenia, we examined the rates and causes of mortality in older adults with schizophrenia who take ...
Raphaëlle Haddad +7 more
doaj +2 more sources
Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database [PDF]
Scientific ReportsRhabdomyolysis is a potentially fatal adverse reaction mainly caused by certain medications. Few real-world studies have shown a clear association between atypical antipsychotics and rhabdomyolysis.
Yi Yin, Jie Jiang, Youpeng Jin
doaj +2 more sources
Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs [PDF]
Annals of General PsychiatryThe 5-hydroxytryptamine receptor (5-HTR) is a key protein responsible for the effects of 5-hydroxytryptamine (5-HT) and an important target for many antipsychotics.
Keying Liu +8 more
doaj +2 more sources
Drugs in Context, 2014 Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD.
Jungjin Kim +2 more
doaj +2 more sources
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
BMC Psychiatry, 2007 Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj +3 more sources
Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System [PDF]
Frontiers in PsychiatryBackgroundCommon atypical antipsychotics include risperidone, paliperidone, olanzapine, lurasidone, quetiapine, clozapine, aripiprazole, ziprasidone, asenapine, brexpiprazole, and cariprazine.
Chao Mu, Li Chen
doaj +2 more sources
Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis [PDF]
Clinical Parkinsonism & Related DisordersIntroduction: Parkinson’s disease (PD) is associated with increased mortality risk (MR), reflecting progression of motor and nonmotor symptoms. PD psychosis (PDP), a common nonmotor symptom, increases with prolonged disease and elevates the MR of PD even
Stuart H. Isaacson +4 more
doaj +2 more sources